$39.31 -0.21 (-0.53%)
2/10/2012 4:00 PM

Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Featured Broker Partners


Advertisement